Loss of mitochondrial membrane potential was found in A-375 melanoma cells in response to the BH3 mimetic gossypol [77], as well as in response to the Mcl-1 antagonist obatoclax in combination with tunicamycin [78]. Here, MCL1 is linked to melanoma.